 |
Articles: Drug/Product Approvals |
Prior Articles
Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment SinemetÂ
Mylan, 10/01/09
ClikSTAR a new reusable insulin pen for use with Lantus and Apidra approved in EU and Canada
Sanofi-aventis, 10/01/09
Free full text
United States Patent Office Allows Claims Covering the Approved Administration of Kuvan with Food
BioMarin, 10/01/09
Free full text
BioSante Pharmaceuticals and Cell Genesys Announce Approval of Merger by BioSante Stockholders and Adjournment of Cell Genesys Stockholders Meeting Until October 2009
Cell Genesys, 10/01/09
Free full text
Covidien Receives FDA Clearance for its Mallinckrodt(TM) TaperGuard(TM) Evac Endotracheal Tube
Covidien, 10/01/09 Cell Therapeutics Applies for European Orphan Drug Designation for Pixantrone in Aggressive Non-Hodgkins Lymphoma
Cell Therapeutics, 09/30/09
Free full text
Survey: Physicians confused about off-label drug use
Medical Economics, 09/29/09 Novartis A(H1N1) Pandemic Influenza vaccine Focetria receives positive opinion from CHMP
Novartis, 09/28/09
Free full text
Merck Statement About JANUVIA™ (sitagliptin) and JANUMET™
Merck & Co., 09/28/09
Free full text
Pandemic (H1N1) 2009 Influenza Update: GSKs H1N1 Pandemrix vaccine receives positive opinion from European Regulators
GlaxoSmithKline, 09/28/09
Free full text
Allos Therapeutics Announces FDA Advisory Committee Recommends Accelerated Approval of FOLOTYN(TM) for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
Allos Therapeutics, 09/28/09
Free full text
Wyeth Receives Positive Opinion from European Regulators for its 13-valent Pneumococcal Candidate Vaccine for Infants and Young Children
Wyeth, 09/28/09
Free full text
Allos Therapeutics' FOLOTYN(TM) First and Only FDA-Approved Therapy for Relapsed or Refractory Peripheral T-cell Lymphoma
Allos Therapeutics, 09/28/09
Free full text
FDA Advisory Committee Hears Presentations and Public Comment on EXALGO Extended-Release Tablets
Covidien, 09/28/09 Multaq Recommended for Approval in the European Union
Sanofi-aventis, 09/28/09
Free full text
Novartis bronchodilator QAB149 recommended for approval in European Union to treat patients with chronic obstructive pulmonary disease
Novartis, 09/28/09
Free full text
Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration
Annals of Pharmacotherapy, 09/25/09 Anti-Cancer Agent Xeloda and Avastin Obtained Approval for Additional Indication of Colorectal Cancer
Chugai Pharmaceutical Co., 09/25/09
Free full text
Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
Cephalon, 09/25/09
Free full text
European Commission Grants Conditional Marketing Authorization to Cayston for the Treatment of Chronic Pulmonary Infections Due to Pseudomonas Aeruginosa in Patients with Cystic Fibrosis
Gilead, 09/24/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
